Latest News for: pd-l1

Edit

Leads Biolabs’ PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Earns EU Orphan Drug Designation—Potential First-in-Class Therapy to ...

GetNews 23 Jan 2026
Opamtistomig (LBL-024) is a potential first-in-class bispecific antibody that simultaneously targets PD-L1 and the co-stimulatory receptor 4-1BB ... for PD-L1 and 4-1BB with an optimized affinity ratio.
Edit

Painter's passion helps villagers realize their dreams on rural canvases

China Daily 22 Jan 2026
ZHENGZHOU — A photo of a group of elderly villagers beaming with joy in front of the Tian'anmen Rostrum, their faces radiating with a warm sense of excitement, recently went viral online. A closer look reveals a heartwarming scene ... 1/3 Next.
×
×
×
×